Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2222-1751
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism ; volume:7 ; number:1 ; day:21 ; month:3 ; year:2018 ; pages:1-15 ; date:12.2018
Emerging Microbes & Infections ; 7, Heft 1 (21.3.2018), 1-15, 12.2018
- Urheber
-
Seesuay, Watee
- Beteiligte Personen und Organisationen
-
Jittavisutthikul, Surasak
Sae-lim, Nawannaporn
Sookrung, Nitat
Sakolvaree, Yuwaporn
Chaicumpa, Wanpen
SpringerLink (Online service)
- DOI
-
10.1038/s41426-018-0031-3
- URN
-
urn:nbn:de:1111-201805263132
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Seesuay, Watee
- Jittavisutthikul, Surasak
- Sae-lim, Nawannaporn
- Sookrung, Nitat
- Sakolvaree, Yuwaporn
- Chaicumpa, Wanpen
- SpringerLink (Online service)
Ähnliche Objekte (12)
Innate Immunity to Ebola virus
Cross-Species Analysis of Innate Immune Antagonism by Cytomegalovirus IE1 Protein
Antagonism of interferon signaling by fibroblast growth factors promotes viral replication
Antagonism of interferon signaling by fibroblast growth factors promotes viral replication
Strategies to interfere with tumor metabolism through the interplay of innate and adaptive immunity
EBOLA
EBOLA
Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology
In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism
II. Points of Antagonism.
Louise Bourgeois: Persistent antagonism
Innate Immunity to Ebola virus
Cross-Species Analysis of Innate Immune Antagonism by Cytomegalovirus IE1 Protein
Antagonism of interferon signaling by fibroblast growth factors promotes viral replication
Antagonism of interferon signaling by fibroblast growth factors promotes viral replication
Strategies to interfere with tumor metabolism through the interplay of innate and adaptive immunity
EBOLA
EBOLA
Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology
In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism
II. Points of Antagonism.
Louise Bourgeois: Persistent antagonism
Innate Immunity to Ebola virus
Cross-Species Analysis of Innate Immune Antagonism by Cytomegalovirus IE1 Protein
Antagonism of interferon signaling by fibroblast growth factors promotes viral replication
Antagonism of interferon signaling by fibroblast growth factors promotes viral replication
Strategies to interfere with tumor metabolism through the interplay of innate and adaptive immunity
EBOLA
EBOLA
Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology
In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism
II. Points of Antagonism.